BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8560580)

  • 1. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measurement of inosine monophosphate dehydrogenase activity in a canine model.
    Langman LJ; Shapiro AM; Lakey JR; LeGatt DF; Kneteman NM; Yatscoff RW
    Transplantation; 1996 Jan; 61(1):87-92. PubMed ID: 8560580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients.
    Langman LJ; LeGatt DF; Halloran PF; Yatscoff RW
    Transplantation; 1996 Sep; 62(5):666-72. PubMed ID: 8830834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.
    Vethe NT; Mandla R; Line PD; Midtvedt K; Hartmann A; Bergan S
    Scand J Clin Lab Invest; 2006; 66(1):31-44. PubMed ID: 16464785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients.
    Fukuda T; Goebel J; Thøgersen H; Maseck D; Cox S; Logan B; Sherbotie J; Seikaly M; Vinks AA
    J Clin Pharmacol; 2011 Mar; 51(3):309-20. PubMed ID: 20418509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil.
    Brunet M; Martorell J; Oppenheimer F; Vilardell J; Millán O; Carrillo M; Rojo I; Corbella J
    Transpl Int; 2000; 13 Suppl 1():S301-5. PubMed ID: 11112019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measuring IMP dehydrogenase activity.
    Langman LJ; LeGatt DF; Yatscoff RW
    Clin Chem; 1995 Feb; 41(2):295-9. PubMed ID: 7874783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization and application of an HPLC method for quantification of inosine-5'-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients.
    Liu F; Xu L; Sheng C; Qiu X; Zhang M; Jiao Z
    Clin Chim Acta; 2018 Oct; 485():333-339. PubMed ID: 29964005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications.
    Weimert NA; Derotte M; Alloway RR; Woodle ES; Vinks AA
    Ther Drug Monit; 2007 Apr; 29(2):141-9. PubMed ID: 17417067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic monitoring of mycophenolic acid in rabbit heterotopic heart transplant model.
    Langman LJ; Nakakura H; Thliveris JA; LeGatt DF; Yatscoff RW
    Ther Drug Monit; 1997 Apr; 19(2):146-52. PubMed ID: 9108641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic Monitoring of Mycophenolic Acid Therapy: Improved Liquid Chromatography-Tandem Mass Spectrometry Method for Measuring Inosin-5'-Monophosphate Dehydrogenase Activity.
    Weißbarth G; Wiesen MHJ; Fietz C; Streichert T; Ehren R; Weber LT; Müller C
    Ther Drug Monit; 2020 Apr; 42(2):282-288. PubMed ID: 31425491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitis.
    Schaier M; Scholl C; Scharpf D; Schmitt WH; Schwenger V; Zeier M; Sommerer C
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i138-45. PubMed ID: 25805745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.
    Bremer S; Vethe NT; Rootwelt H; Jørgensen PF; Stenstrøm J; Holdaas H; Midtvedt K; Bergan S
    J Transl Med; 2009 Jul; 7():64. PubMed ID: 19635156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients.
    Neuberger M; Sommerer C; Böhnisch S; Metzendorf N; Mehrabi A; Stremmel W; Gotthardt D; Zeier M; Weiss KH; Rupp C
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):543-550. PubMed ID: 31924555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of IMPDH1 is regulated in response to mycophenolate concentration.
    Bremer S; Vethe NT; Rootwelt H; Bergan S
    Int Immunopharmacol; 2009 Feb; 9(2):173-80. PubMed ID: 19010451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients.
    Glander P; Hambach P; Braun KP; Fritsche L; Waiser J; Mai I; Neumayer HH; Budde K
    Int J Clin Pharmacol Ther; 2003 Oct; 41(10):470-6. PubMed ID: 14703953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and intracellular pharmacokinetic-pharmacodynamic analysis of mycophenolic acid in de novo kidney transplant patients.
    Thi MT; Mourad M; Capron A; Tshinanu FM; Vincent MF; Wallemacq P
    Clin Biochem; 2015 Apr; 48(6):401-5. PubMed ID: 25523299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and application of a high-performance liquid chromatography-based assay for determination of the activity of inosine 5'-monophosphate dehydrogenase in whole blood and isolated mononuclear cells.
    Albrecht W; Storck M; Pfetsch E; Martin W; Abendroth D
    Ther Drug Monit; 2000 Jun; 22(3):283-94. PubMed ID: 10850395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid.
    Rother A; Glander P; Vitt E; Czock D; von Ahsen N; Armstrong VW; Oellerich M; Budde K; Feneberg R; Tönshoff B; Weber LT
    Eur J Clin Pharmacol; 2012 Jun; 68(6):913-22. PubMed ID: 22274404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
    Vethe NT; Bergan S
    Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals.
    Vethe NT; Bremer S; Rootwelt H; Bergan S
    Ther Drug Monit; 2008 Dec; 30(6):647-55. PubMed ID: 18806697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.